First AD

Second AD

Following an overview of the evolving adjuvant therapy space, Matthew Milowsky, MD, FASCO, reviews recent updates from ASCO GU 2024 in MIBC.

Recent Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer

Genitourinary Cancers

EXE-22-OSD1273 - /clinical/genitourinary-cancer

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research. 

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Advancing Treatments for Bladder Cancer: Insights from ASCO GU 2024

Peer Exchange

Fox Chase Cancer Center

Cancer Centers

Partner

Huntsman Cancer Institute at the University of Utah 

University of North Carolina, Lineberger Comprehensive Cancer Center

Fred Hutch Cancer Center

Following an overview of the evolving adjuvant therapy space, Matthew Milowsky, MD, FASCO, reviews recent updates from ASCO GU 2024 in muscle-invasive bladder cancer.

Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer (MIBC)

Ongoing Research on Neoadjuvant Therapies in Muscle-Invasive Bladder Cancer

Expert Insights on Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer

Emerging Data in Metastatic Urothelial Carcinoma

Clinical Insights on Recent Data in Metastatic Urothelial Carcinoma

Cisplatin Eligibility and Maintenance Therapy in Metastatic Urothelial Carcinoma

Later-Line Therapies for Metastatic Urothelial Carcinoma

Treatment Sequencing Practices in Metastatic Urothelial Carcinoma

Exciting New Approaches in Metastatic Urothelial Carcinoma

Key Takeaways on Updates in Bladder Cancer